
Sign up to save your podcasts
Or


Prof. David Tizzard of Korean Studies at both Seoul Women University and Hanyang University and a columnist for the Korea Times will talk about a groundbreaking gene-editing treatment that’s reversing an otherwise incurable blood cancer.
By Arirang RadioProf. David Tizzard of Korean Studies at both Seoul Women University and Hanyang University and a columnist for the Korea Times will talk about a groundbreaking gene-editing treatment that’s reversing an otherwise incurable blood cancer.